Clinical trials experts have emphasized the importance of keeping states informed about ongoing clinical trials in India. The experts highlighted the need for better communication and transparency between the central government and state authorities regarding these trials. This call for improved communication comes in light of recent controversies and concerns surrounding clinical trials in the country. There have been instances where states were not adequately informed about trials being conducted within their jurisdictions, leading to confusion and lack of oversight. Experts argue that involving state governments in the decision-making process and keeping them informed about the progress of clinical trials can help ensure better monitoring and adherence to regulations. Additionally, they stress the need for a standardized protocol for sharing information and data related to clinical trials to promote accountability and transparency. By involving states more actively in the clinical trial process, experts believe that the overall quality and safety of trials can be enhanced, ultimately benefiting both the participants and the broader public. Improved communication and collaboration between central and state authorities are essential to address the challenges and concerns surrounding clinical trials in India.